Daiichi Sankyo Company, Limited (DSKYF)
OTCMKTS · Delayed Price · Currency is USD
18.97
+0.35 (1.88%)
Feb 23, 2026, 1:58 PM EST
Daiichi Sankyo Company Market Cap
Daiichi Sankyo Company has a market cap or net worth of $35.65 billion as of February 24, 2026. Its market cap has decreased by -33.37% in one year.
Market Cap
35.65B
Enterprise Value
34.08B
Revenue
13.09B
Ranking
n/a
PE Ratio
18.35
Stock Price
$18.97
Market Cap Chart
Since September 28, 2005, Daiichi Sankyo Company's market cap has increased from 2.93B to 35.65B, an increase of 1,118.19%. That is a compound annual growth rate of 13.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 34.81B | -12.23% |
| Dec 30, 2025 | 39.66B | -23.97% |
| Dec 30, 2024 | 52.16B | -0.97% |
| Dec 29, 2023 | 52.67B | -14.75% |
| Dec 30, 2022 | 61.78B | 26.88% |
| Dec 30, 2021 | 48.69B | -26.63% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 791.42M |
| Veradigm | 732.75M |
| Glass House Brands | 651.25M |
| American Oncology Network | 389.18M |
| Elite Pharmaceuticals | 387.58M |
| Northwest Biotherapeutics | 383.41M |
| CytoDyn | 330.55M |
| OpGen | 292.16M |